Quest Diagnostics EBIT 2010-2025 | DGX

Quest Diagnostics EBIT for the quarter ending March 31, 2025 was $0.346B, a 15.33% increase year-over-year.

  • Quest Diagnostics 2024 EBIT was 1.346B, a 6.66% increase from 2023.
  • Quest Diagnostics 2023 EBIT was 1.262B, a 11.62% decline from 2022.
  • Quest Diagnostics 2022 EBIT was 1.428B, a 40.03% decline from 2021.

EBIT can be defined as earnings before interest and taxes.

Quest Diagnostics EBIT 2010-2025 | DGX

  • Quest Diagnostics 2024 EBIT was 1.346B, a 6.66% increase from 2023.
  • Quest Diagnostics 2023 EBIT was 1.262B, a 11.62% decline from 2022.
  • Quest Diagnostics 2022 EBIT was 1.428B, a 40.03% decline from 2021.

EBIT can be defined as earnings before interest and taxes.
Related Stocks
Company NameMarket
Cap
DaVita (DVA)$11.2B
Encompass Health (EHC)$10.4B
Chemed (CHE)$8.5B
Option Care Health (OPCH)$5.3B
Elanco Animal Health (ELAN)$4.2B
RadNet (RDNT)$3.7B
Amedisys (AMED)$3B
LifeStance Health (LFST)$2.6B
Addus HomeCare (ADUS)$1.8B
Astrana Health (ASTH)$1.6B
U.S Physical Therapy (USPH)$1B
Pennant (PNTG)$907M
Aveanna Healthcare Holdings (AVAH)$886M
Atai Life Sciences (ATAI)$294M
Daxor (DXR)$36M
Ontrak (OTRK)$6M
MEDIROM Healthcare Technologies (MRM)$4M
Psychemedics (PMD)$0M